home of the INTERNATIONAL ATHEROSCLEROSIS SOCIETY
  ABOUT IAS  | IAS LEADERSHIP  | MEMBER SOCIETIES  | MEMBERSHIP contact us  | home   

IAS Prevention Guideline plus relevant cardiovascular guidelines from other organizations
Previous and future meetings sponsored by the IAS, the IAS member societies, or relevant affiliated organizations
Current and prior publications that have been sponsored by the IAS, including previous IAS newsletters
Distinguished Fellows of the IAS
Slides available through the IAS, Lorenzini Foundation, and other sites.
IAS monthly newsletter sent by email to all IAS members
The IAS offers fellowships to young investigators to study in major laboratories
Important websites related to atherosclerosis and related diseases
Organizations affiliated with the IAS.


IAS Statin Publication
Update Service


The International Atherosclerosis Society is very pleased to announce an exciting new and informative Newsletter for its membership: The IAS Statin Newsletter. The IAS will begin this month providing curated update on all publications involving statins as identified in PubMed.
For the Issues, click here

ISA 2018 Toronto, Canada

June 9-12, 2018

XVIII International Symposium on
Atherosclerosis
Toronto, Canada


Final Program

Abstract Book

Photos of the Opening Ceremony

Highlights from the Joint Satellite Symposium of the IAS and ICCR Session on Visceral Adiposity

Fellowship Awards
Winners 2018


Chiara Macchi
Milan, Italy


Dorothè Maria Kusters
Amsterdam, The Netherlands


Nerea Mendez Barbero
Madrid, Spain


Winner Reports
Winner 2016 - Blake Cochran
Winner 2016 - Ingo Hilgendorf
Winner 2016 - Yosdel Soto
Winner 2015 - Hagit Hochner
Winner 2015 - Kazuyuki Kasahara
Winner 2015 - Wei Tan
Winner 2014 - Amanda Foks
Winner 2014 - Nordin Hanssen
Winner 2014 - Marco Busnelli

last updated: November 8, 2018 

  From the IAS President's Desk


Yuji Matsuzawa

I am pleased to announce that the International Atherosclerosis Society (IAS) and the FH Foundation, a patient-centered nonprofit organization dedicated to research, advocacy, and education of familial hypercholesterolemia (FH), have joined in partnership to improve awareness of FH and elevate FH on the global policy stage. FH is the most common genetic condition leading to very high cholesterol and early heart disease. One in 220 people or 30 million worldwide have FH, but 90% are undiagnosed. Press Release

LET'S KEEP IN TOUCH
I am pleased to announce that the IAS is now on social media.
Facebook: https://www.facebook.com/atherosociety/
Twitter: https://twitter.com/atherosociety
LinkedIn: https://www.linkedin.com/groups/8689597/

Facebook  Twitter  Linkedin



  IAS Session at GW-ICC 2018 Beijing
GW-ICC


The Great Wall Congress in Beijing just concluded and the IAS is honored to inform that the Session focused on Defining Severe FH and The Implications for Clinical Management held on October 12 took place successfully.

  IAS FH Activities

    ANNOUNCING THE IAS-FH FOUNDATION PARTNERSHIP

  • FH Foundation

  • FH Awareness Media Kit by the FH Foundation

  • FH Foundation - Consensus Statement on Genetic Testing for FH - 2018

  • FHFo/IAS Joint Session on “Recognize Familial Hypercholesterolemia and Save Lives“ during the WCC 2018 Congress (Dubai, UAE, December 8, 2018)

  • IberoAmerican FH Network    -    Mona Lisa Video

  • IAS Consensus Statement “Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel” - 2016

  • New Data on Familial Hypercholesterolemia in Brazil - 2017

  • ScreenPro - Screening Project for Familial Hypercholesterolemia in Central, Southern, and Eastern Europe

  • News from the Iraqi Lipid Clinics Network

  • The SAFEHEART Registry

  • E-Learning cor2ed

  • Severe FH Course “Identifying and Treating Severe Familial Hypercholesterolemia” (Dubai, UAE, October 14-15, 2017)


  XIX International Symposium on Atherosclerosis 2021

Pre-Satellite Symposium (Muscat, Oman, October 19-21, 2021)

ISA2021 Congress (Kyoto, Japan, October 24-27, 2021)


  XX International Atherosclerosis Society 2024 - Winner

We are pleased to announce that after the presentation of the outstanding bids for the ISA2024 Symposium from the Russian National Atherosclerosis Society (RNAS), Emirates Cardiac Society (ECS), Lipid Association of India (LAI), and Oman Society of Lipids & Atherosclerosis (OSLA) the IAS Executive Board during its meeting held in Toronto on June 9 has selected the winner of the ISA2024: the Oman Society of Lipids and Atherosclerosis (OSLA).


  IAS - OSLA Collaboration in the MENA Region

The International Atherosclerosis Society (IAS) and Oman Society of Lipid & Atherosclerosis (OSLA) are organizing the Fifth IAS-OSLA Course "Lipid Metabolism and Cardiovascular Risk" to be held in Muscat, Oman, on February 8-12, 2019.
As in 2015, 2016, 2017 and 2018, the aim of this Course is to increase the knowledge and experience of early- to mid-career, English-speaking practicing clinicians interested in the management of lipid disorders and will be restricted to 30 clinicians from the Middle East and North Africa (MENA) region who manage patients with lipid disorders.

Who can apply: Clinicians (including adult or pediatric cardiologists, endocrinologists, general practitioners, lipidologists, clinical biochemists) below the age of 40 years who are currently working at a hospital/university/other health institute in the MENA region.

More information will follow.


  IAS Commentaries

  Meeting and Educational Activity Highlights
To view all highlights, please click here

  Acknowledgements
The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission:
Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Amryt, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, OSLA - Oman Society of Lipids and Atherosclerosis, Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd.,Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College


Disclaimer - Cookie policy
This site is optimised for a min. 1024 x 768 pixels resolution

REGISTERED USER
USER ID


PASSWORD




Remember my password


Forgot your password?
Click here


First-time user?
Click here


WHO IS IAS

The International Atherosclerosis Society (IAS), incorporated in 1979, promotes, at an international level, the advancement of science, research and teaching in the field of atherosclerosis and related diseases.

IAS Newsletter Editors & Website Editorial Board

Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta
Milan, Italy

Emanuela Folco
Milan, Italy

Ann Jackson
Houston, TX, USA

Commentary & Newsletter Editor
Yelonda Williams
(Dallas, TX, USA)

Elena Colombo
(Milan, Italy)